Company
LAVA Therapeutics
Innovation in ENGAGING GAMMA DELTA T CELLS to potently and precisely fight cancer
Also known as LAVA Therapeutics N.V.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- LAVA Therapeutics N.V.
Claim, correct or request removal
Record updated 28 September 2026
About
At LAVA, we are focused on developing OUR GAMMABODY® PLATFORM to transform cancer therapy. Our Gammabody® platform generates bispecific gamma delta T cell engagers that specifically activate a unique and relatively abundant effector gamma-delta T cell subset called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells.
Products
- Other
- Gammabody® Platform
Loading relationship preview